Shenzhen Lifotronic Technology Co., Ltd. 688389.SS Stock
Shenzhen Lifotronic Technology Co., Ltd. Price Chart
Shenzhen Lifotronic Technology Co., Ltd. 688389.SS Financial and Trading Overview
Contents
- Shenzhen Lifotronic Technology Co., Ltd. Price Chart
- Shenzhen Lifotronic Technology Co., Ltd. 688389.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shenzhen Lifotronic Technology Co., Ltd.
- Q&A For Shenzhen Lifotronic Technology Co., Ltd. Stock
Shenzhen Lifotronic Technology Co., Ltd. stock price | 18.06 CNY |
Previous Close | 24 CNY |
Open | 23.61 CNY |
Bid | 23.5 CNY x N/A |
Ask | 23.55 CNY x N/A |
Day's Range | 23.14 - 24.28 CNY |
52 Week Range | 14.16 - 30.57 CNY |
Volume | 2.2M CNY |
Avg. Volume | 2.26M CNY |
Market Cap | 10.37B CNY |
Beta (5Y Monthly) | 0.361836 |
PE Ratio (TTM) | 37.301586 |
EPS (TTM) | 0.77 CNY |
Forward Dividend & Yield | 0.24 (1.00%) |
Ex-Dividend Date | June 8, 2023 |
1y Target Est | N/A |
688389.SS Valuation Measures
Enterprise Value | 9.27B CNY |
Trailing P/E | 37.301586 |
Forward P/E | 22.596155 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 9.870902 |
Price/Book (mrq) | 6.2516627 |
Enterprise Value/Revenue | 8.82 |
Enterprise Value/EBITDA | 36.536 |
Trading Information
Shenzhen Lifotronic Technology Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.361836 |
52-Week Change | 37.53% |
S&P500 52-Week Change | 20.43% |
52 Week High | 30.57 CNY |
52 Week Low | 14.16 CNY |
50-Day Moving Average | 26.14 CNY |
200-Day Moving Average | 22.12 CNY |
688389.SS Share Statistics
Avg. Volume (3 month) | 2.26M CNY |
Avg. Daily Volume (10-Days) | 1.95M CNY |
Shares Outstanding | 425.64M |
Float | 182.25M |
Short Ratio | N/A |
% Held by Insiders | 65.80% |
% Held by Institutions | 7.44% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.237 |
Trailing Annual Dividend Yield | 0.98% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2738 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 25.92% |
Operating Margin (ttm) | 21.92% |
Gross Margin | 59.05% |
EBITDA Margin | 24.13% |
Management Effectiveness
Return on Assets (ttm) | 8.24% |
Return on Equity (ttm) | 18.56% |
Income Statement
Revenue (ttm) | 1.05B CNY |
Revenue Per Share (ttm) | 2.51 CNY |
Quarterly Revenue Growth (yoy) | 32.30% |
Gross Profit (ttm) | 983.04M CNY |
EBITDA | 253.67M CNY |
Net Income Avi to Common (ttm) | 272.46M CNY |
Diluted EPS (ttm) | 0.63 |
Quarterly Earnings Growth (yoy) | 31.19% |
Balance Sheet
Total Cash (mrq) | 1B CNY |
Total Cash Per Share (mrq) | 2.35 CNY |
Total Debt (mrq) | 136.15M CNY |
Total Debt/Equity (mrq) | 8.49 CNY |
Current Ratio (mrq) | 3.634 |
Book Value Per Share (mrq) | 3.759 |
Cash Flow Statement
Operating Cash Flow (ttm) | 275.79M CNY |
Levered Free Cash Flow (ttm) | -40395588 CNY |
Profile of Shenzhen Lifotronic Technology Co., Ltd.
Country | China |
State | N/A |
City | Shenzhen |
Address | Building 15 |
ZIP | 518000 |
Phone | 86 75 5290 16066 |
Website | https://www.lifotronic.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 1375 |
Shenzhen Lifotronic Technology Co., Ltd. develops, manufactures, and markets medical devices for diagnostic and therapeutic purposes in China. The company offers IVD products, such as HPLC systems, including hemoglobin and HbA1c analyzers, ECLIA systems comprising automated ECL immunoassay analyzers; hematology analyzers; POCT, such as immunofluorescence analyzers; molecular diagnostics, including automated nucleic acid purification system and real-time PCR systems; and rapid tests for COVID-19, malaria, dengue, and influenza A and B. It also provides therapeutic products comprising respiratory and ICU products, such as video laryngoscope, warmer unit with disposable blanket, high-flow humidification systems, high frequency chestwall oscillation, and intermittent pneumatic compression pumps; wound care products, including negative pressure wound therapy, ultrasound-assisted wound debridement, and wound healing light therapy; and ESWT pain management products comprising electromagnetic shockwave and extracorporeal shock wave therapy. In addition, the company's medical and aesthetic laser products comprises of intensive pulse light, fractional CO2 laser systems, Q-switched Nd:YAG laser systems, and fiber laser hair removal systems. Shenzhen Lifotronic Technology Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.
Q&A For Shenzhen Lifotronic Technology Co., Ltd. Stock
What is a current 688389.SS stock price?
Shenzhen Lifotronic Technology Co., Ltd. 688389.SS stock price today per share is 18.06 CNY.
How to purchase Shenzhen Lifotronic Technology Co., Ltd. stock?
You can buy 688389.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shenzhen Lifotronic Technology Co., Ltd.?
The stock symbol or ticker of Shenzhen Lifotronic Technology Co., Ltd. is 688389.SS.
Which industry does the Shenzhen Lifotronic Technology Co., Ltd. company belong to?
The Shenzhen Lifotronic Technology Co., Ltd. industry is Medical Devices.
How many shares does Shenzhen Lifotronic Technology Co., Ltd. have in circulation?
The max supply of Shenzhen Lifotronic Technology Co., Ltd. shares is 428.11M.
What is Shenzhen Lifotronic Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shenzhen Lifotronic Technology Co., Ltd. PE Ratio is 23.45454600 now.
What was Shenzhen Lifotronic Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shenzhen Lifotronic Technology Co., Ltd. EPS is 0.77 CNY over the trailing 12 months.
Which sector does the Shenzhen Lifotronic Technology Co., Ltd. company belong to?
The Shenzhen Lifotronic Technology Co., Ltd. sector is Healthcare.